Cebranopadol, a Novel First-In-Class Analgesic Drug Candidate

Pain - United States
doi 10.1097/j.pain.0000000000000986
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Correction To: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-In-Class Analgesic

Clinical Pharmacokinetics
Pharmacology
2018English

Exosome Mimetics: A Novel Class of Drug Delivery Systems

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

A Novel Alzheimer’s Disease Drug Candidate Targeting Inflammation and Fatty Acid Metabolism

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2017English

From Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial Agents

Frontiers in Microbiology
Microbiology
2019English

Novel and Efficient Synthesis of the Promising Drug Candidate Discodermolide

2009English

Triple Class HIV-1 Drug Resistance in Croatia: The First Report

Knj. 48-49(2019)
2019English

DT-0111: A Novel Drug-Candidate for the Treatment of COPD and Chronic Cough

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2019English

Role of Neuroimaging in Analgesic Drug Development

Drugs in R and D
Pharmacology
2008English

Adhesion G Protein-Coupled Receptors - Candidate Metabotropic Mechanosensors and Novel Drug Targets

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy